Oruka Therapeutics, Inc. Common Stock
Symbol: ORKA (NASDAQ)
19.41
▲ (0.60%) 0.116
Company Description:
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
Key Stats
- Today's Open: $19.05
- Today's High: $19.69
- Today's Low: $18.36
- Today's Volume: 363.32K
- Yesterday Close: $19.29
- Yesterday High: $20
- Yesterday Low: $15.77
- Yesterday Volume: 1.35M
- Last Min Volume: 1.71K
- Last Min High: $19.549
- Last Min Low: $19.438
- Last Min VWAP: $19.49984
Company Profile
- Name: Oruka Therapeutics, Inc. Common Stock
- Website: https://www.orukatx.com
- Listed Date: 2024-09-03
- Location: MENLO PARK, CA
- Market Status: Active
- CIK Number: 0000907654
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $933.33M
- Round Lot: 100
- Outstanding Shares: 48.38M
- Asset Type: CS
RECENT FILINGS FOR ORKA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-24 | SCHEDULE 13G | View |
| 2025-09-22 | 424B3 | View |
| 2025-09-22 | 8-K | View |
| 2025-09-19 | SCHEDULE 13D/A | View |
| 2025-09-19 | 4 | View |
| 2025-08-11 | 424B3 | View |
| 2025-08-11 | 10-Q | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 3 | View |
| 2025-07-01 | 8-K | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-14 | 424B3 | View |
| 2025-05-14 | 10-Q | View |
Latest News on ORKA